RANDHAWA SIMRAT (EVP, Head of R&D) sold 86.9% of their position (26.53K shares) of DIANTHUS THERAPEUTICS, INC. /DE/ on the open market
Open‑market sale worth $2.40M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+4K
Price / share
$8.44
Trade value
$33.74K
% of position
Common Stock
Shares
+6.91K
Price / share
$17.88
Trade value
$123.52K
% of position
Common Stock
Shares
+6.25K
Price / share
$21.77
Trade value
$136.04K
% of position
Common Stock
Shares
+9.38K
Price / share
$22.07
Trade value
$206.91K
% of position
Common Stock
Shares
−5.43K
Price / share
$89.72
Trade value
$487K
% of position
Common Stock
Shares
−16.94K
Price / share
$90.72
Trade value
$1.54M
% of position
Common Stock
Shares
−4.16K
Price / share
$91.37
Trade value
$380.01K
% of position
Net shares
+0.00
Net value
-$1.90M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | M · Option Exercise | +4K | $8.44 | $33.74K | 100.0% | 4K | 8K |
| Common Stock Direct | 6/1/2026 | M · Option Exercise | +6.91K | $17.88 | $123.52K | 86.4% | 8K | 14.91K |
| Common Stock Direct | 6/1/2026 | M · Option Exercise | +6.25K | $21.77 | $136.04K | 41.9% | 14.91K | 21.16K |
| Common Stock Direct | 6/1/2026 | M · Option Exercise | +9.38K | $22.07 | $206.91K | 44.3% | 21.16K | 30.53K |
| Common Stock Direct | 6/1/2026 | S · Sale | −5.43K | $89.72 | $487K | 17.8% | 30.53K | 25.10K |
| Common Stock Direct | 6/1/2026 | S · Sale | −16.94K | $90.72 | $1.54M | 67.5% | 25.10K | 8.16K |
| Common Stock Direct | 6/1/2026 | S · Sale | −4.16K | $91.37 | $380.01K | 51.0% | 8.16K | 4K |
| Total | +0.00 | -$1.90M | ||||||
Stock Option (Right to Buy)
Common Stock
4K shares
Shares
−4K
Strike price
8.44
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
6.91K shares
Shares
−6.91K
Strike price
17.88
Held after
64.28K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
6.25K shares
Shares
−6.25K
Strike price
21.77
Held after
47.92K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
9.38K shares
Shares
−9.38K
Strike price
22.07
Held after
96.88K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4K shares | 6/1/2026 | M · Option Exercise | −4K | 8.44 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock6.91K shares | 6/1/2026 | M · Option Exercise | −6.91K | 17.88 | — | 64.28K |
| Stock Option (Right to Buy) Direct | Common Stock6.25K shares | 6/1/2026 | M · Option Exercise | −6.25K | 21.77 | — | 47.92K |
| Stock Option (Right to Buy) Direct | Common Stock9.38K shares | 6/1/2026 | M · Option Exercise | −9.38K | 22.07 | — | 96.88K |